DiscoverBlood & CancerHow to kill a trial
How to kill a trial

How to kill a trial

Update: 2020-11-17
Share

Description

The Tomosynthesis Mammography Imaging Screening Trial (TMIST) was designed to see if 3-D mammography, or tomosynthesis, could help personalize screening and if 3-D is actually better than the less expensive 2-D mammography.

TMIST is the largest breast cancer screening trial in the United States, with a cost of $100 million and a planned enrollment of 165,000 women.

There's just one problem. The study is falling short on enrollment of patients and participating sites. Will this mean the death of TMIST?

For more details, see coverage of TMIST on Medscape:
NCI May 'Kill' Major Mammography Trial, Says Advisor
https://www.medscape.com/viewarticle/937918

Email Blood & Cancer at podcasts@mdedge.com.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How to kill a trial

How to kill a trial

Medscape Professional Network